The effect of probiotics supplementation in postoperative cancer patients: a prospective pilot study
| Autor: | Song Hwa Chae, O-Hyun Ban, Hyo Jin Jung, Jung Ha Kim, Daeyoun David Won, Jungwoo Yang, Hae Myung Jeon, Hyeji Kwon, Hyeon Min Shin, Ji Eun Jeong, Jong Kyun Lee, Yong Won Kang, Chan Kum Park |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Quality of life
medicine.medical_specialty Weissella Gut microbiota Gut flora Gastroenterology law.invention Probiotic law Internal medicine Medicine Postoperative Sleep disorder biology business.industry Probiotics Bacteroidetes Cancer Cancer patients Fusobacteria biology.organism_classification medicine.disease Original Article Surgery business |
| Zdroj: | Annals of Surgical Treatment and Research |
| ISSN: | 2288-6796 2288-6575 |
| DOI: | 10.4174/astr.2021.101.5.281 |
| Popis: | Purpose Microbiota manipulation through selected probiotics may be a promising tool to prevent cancer development as well as onset, to improve clinical efficacy for cancer treatments. The purpose of this study was to evaluate change in microbiota composition after-probiotics supplementation and assessed the efficacy of probiotics in improving quality of life (QOL) in postoperative cancer patients. Methods Stool samples were collected from 30 cancer patients from February to October 2020 before (group I) and after (group II) 8 weeks of probiotics supplementation. We performed 16S ribosomal RNA gene sequencing to evaluate differences in gut microbiota between groups by comparing gut microbiota diversity, overall composition, and taxonomic signature abundance. The health-related QOL was evaluated through the EORTC Quality of life Questionnaire Core 30 questionnaire. Results Statistically significant differences were noted in group II; increase of Shannon and Simpson index (P = 0.004 and P = 0.001), decrease of Bacteroidetes and Fusobacteria at the phylum level (P = 0.032 and P = 0.014, retrospectively), increased of beneficial bacteria such as Weissella (0.096% vs. 0.361%, P < 0.004), Lactococcus (0.023% vs. 0.16%, P < 0.001), and Catenibacterium (0.0% vs. 0.005%, P < 0.042) at the genus level. There was a significant improvement in sleep disturbance (P = 0.039) in group II. Conclusion Gut microbiota in cancer patients can be manipulated by specific probiotic strains, result in an altered microbiota. Microbiota modulation by probiotics can be considered as part of a supplement that helps to increase gut microbiota diversity and improve QOL in cancer patients after surgery. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|